Systemic Bevacizumab (Avastin) Therapy for Neovascular Age-Related Macular Degeneration: Twenty-Four–Week Results of an Uncontrolled Open-Label Clinical Study
- 1 January 2007
- journal article
- Published by Elsevier in Yearbook of Ophthalmology
- Vol. 2007, 140-141
- https://doi.org/10.1016/s0084-392x(08)70111-4
Abstract
No abstract availableThis publication has 1 reference indexed in Scilit: